<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>27(4)</volume><submitter>Utsugi Y</submitter><pubmed_abstract>Coronavirus disease 2019 (COVID-19) is endemic worldwide. Cardiovascular disease, particularly myocarditis, is one of the most common comorbidities in patients with COVID-19. However, heart failure due to COVID-19-triggered cardiomyopathy is not well understood. Additionally, "pseudo" heart failure symptoms have been reported in patients with a compensated condition, in which the heart works well enough that symptoms are unnoticeable or very easy to manage. Here, we report a case of heart failure due to cardiomyopathy in a patient with COVID-19 and postural orthostatic tachycardia syndrome after heart failure treatment.&lt;h4>Learning objective&lt;/h4>Postural orthostatic tachycardia syndrome (POTS) symptoms after coronavirus disease 2019 may be mistaken for heart failure symptoms; thus, it is e</pubmed_abstract><journal>Journal of cardiology cases</journal><pagination>156-158</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9780634</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Noteworthy sequelae after COVID-19 pneumonia in a patient with heart failure due to cardiomyopathy.</pubmed_title><pmcid>PMC9780634</pmcid><pubmed_authors>Doi S</pubmed_authors><pubmed_authors>Suzuki N</pubmed_authors><pubmed_authors>Akashi YJ</pubmed_authors><pubmed_authors>Harada T</pubmed_authors><pubmed_authors>Ishibashi Y</pubmed_authors><pubmed_authors>Utsugi Y</pubmed_authors><pubmed_authors>Izumo M</pubmed_authors><pubmed_authors>Kuwata S</pubmed_authors><pubmed_authors>Sato Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Noteworthy sequelae after COVID-19 pneumonia in a patient with heart failure due to cardiomyopathy.</name><description>Coronavirus disease 2019 (COVID-19) is endemic worldwide. Cardiovascular disease, particularly myocarditis, is one of the most common comorbidities in patients with COVID-19. However, heart failure due to COVID-19-triggered cardiomyopathy is not well understood. Additionally, "pseudo" heart failure symptoms have been reported in patients with a compensated condition, in which the heart works well enough that symptoms are unnoticeable or very easy to manage. Here, we report a case of heart failure due to cardiomyopathy in a patient with COVID-19 and postural orthostatic tachycardia syndrome after heart failure treatment.&lt;h4>Learning objective&lt;/h4>Postural orthostatic tachycardia syndrome (POTS) symptoms after coronavirus disease 2019 may be mistaken for heart failure symptoms; thus, it is e</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Apr</publication><modification>2025-04-05T13:22:09.832Z</modification><creation>2024-11-20T23:16:28.552Z</creation></dates><accession>S-EPMC9780634</accession><cross_references><pubmed>36575713</pubmed><doi>10.1016/j.jccase.2022.12.006</doi></cross_references></HashMap>